These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25391884)

  • 1. Oxidative stress contributes to muscle atrophy in chronic kidney disease patients.
    Beetham KS; Howden EJ; Small DM; Briskey DR; Rossi M; Isbel N; Coombes JS
    Redox Rep; 2015 May; 20(3):126-32. PubMed ID: 25391884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress is associated with decreased heart rate variability in patients with chronic kidney disease.
    Fadaee SB; Beetham KS; Howden EJ; Stanton T; Isbel NM; Coombes JS
    Redox Rep; 2017 Sep; 22(5):197-204. PubMed ID: 27090392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and urinary F
    Granick M; Leuin AS; Trepanier LA
    J Feline Med Surg; 2021 Aug; 23(8):692-699. PubMed ID: 33146574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of plasma F2-isoprostanes and isofurans concentrations with erythropoiesis-stimulating agent resistance in maintenance hemodialysis patients.
    Rivara MB; Ikizler TA; Ellis CD; Mehrotra R; Himmelfarb J
    BMC Nephrol; 2015 Jun; 16():79. PubMed ID: 26045064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aerobic training reduces systemic oxidative stress in young women with elevated levels of F2-isoprostanes.
    Arikawa AY; Thomas W; Gross M; Smith A; Phipps WR; Kurzer MS; Schmitz KH
    Contemp Clin Trials; 2013 Mar; 34(2):212-7. PubMed ID: 23178737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated plasma F2-isoprostanes in patients on long-term hemodialysis.
    Handelman GJ; Walter MF; Adhikarla R; Gross J; Dallal GE; Levin NW; Blumberg JB
    Kidney Int; 2001 May; 59(5):1960-6. PubMed ID: 11318969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated plasma F2-isoprostane levels in schizophrenia.
    Lee EE; Eyler LT; Wolkowitz OM; Martin AS; Reuter C; Kraemer H; Jeste DV
    Schizophr Res; 2016 Oct; 176(2-3):320-326. PubMed ID: 27318521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. F2-isoprostanes as biomarkers of lipid peroxidation in patients with chronic renal failure.
    Wiswedel I; Hirsch D; Carluccio F; Hampl H; Siems W
    Biofactors; 2005; 24(1-4):201-8. PubMed ID: 16403981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability of oxidative stress biomarkers in hemodialysis patients.
    Dahwa R; Fassett RG; Wang Z; Briskey D; Mallard AR; Coombes JS
    Biomarkers; 2014 Mar; 19(2):154-8. PubMed ID: 24520971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD.
    Ramos LF; Shintani A; Ikizler TA; Himmelfarb J
    J Am Soc Nephrol; 2008 Mar; 19(3):593-9. PubMed ID: 18256365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney disease.
    Rossi M; Campbell KL; Johnson DW; Stanton T; Vesey DA; Coombes JS; Weston KS; Hawley CM; McWhinney BC; Ungerer JP; Isbel N
    Arch Med Res; 2014 May; 45(4):309-17. PubMed ID: 24751327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between three major physiological stress systems and oxidative DNA and lipid damage.
    Black CN; Bot M; Révész D; Scheffer PG; Penninx B
    Psychoneuroendocrinology; 2017 Jun; 80():56-66. PubMed ID: 28319849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of plasma total F2-isoprostanes before and after hemodialysis in end-stage renal disease patients.
    Kim KM; Jung BH; Paeng KJ; Kim SW; Chung BC
    Prostaglandins Leukot Essent Fatty Acids; 2004 May; 70(5):475-8. PubMed ID: 15062851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary F
    Whitehouse W; Quimby J; Wan S; Monaghan K; Robbins R; Trepanier LA
    J Vet Intern Med; 2017 Mar; 31(2):449-456. PubMed ID: 28160524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-free hemoglobin mediated oxidative stress is associated with acute kidney injury and renal replacement therapy in severe falciparum malaria: an observational study.
    Plewes K; Kingston HWF; Ghose A; Maude RJ; Herdman MT; Leopold SJ; Ishioka H; Hasan MMU; Haider MS; Alam S; Piera KA; Charunwatthana P; Silamut K; Yeo TW; Faiz MA; Lee SJ; Mukaka M; Turner GDH; Anstey NM; Jackson Roberts L; White NJ; Day NPJ; Hossain MA; Dondorp AM
    BMC Infect Dis; 2017 Apr; 17(1):313. PubMed ID: 28449641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxynitrite-induced oxidation of plasma lipids is enhanced in stable hemodialysis patients.
    Ferraro B; Galli F; Frei B; Kingdon E; Canestrari F; Rice-Evans C; Buoncristiani U; Davenport A; Moore KP
    Kidney Int; 2003 Jun; 63(6):2207-13. PubMed ID: 12753309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma biomarkers of oxidant stress and development of organ failure in severe sepsis.
    Ware LB; Fessel JP; May AK; Roberts LJ
    Shock; 2011 Jul; 36(1):12-7. PubMed ID: 21372753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress in human hypertension: association with antihypertensive treatment, gender, nutrition, and lifestyle.
    Ward NC; Hodgson JM; Puddey IB; Mori TA; Beilin LJ; Croft KD
    Free Radic Biol Med; 2004 Jan; 36(2):226-32. PubMed ID: 14744634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and research markers of oxidative stress in chronic kidney disease.
    Tucker PS; Dalbo VJ; Han T; Kingsley MI
    Biomarkers; 2013 Mar; 18(2):103-15. PubMed ID: 23339563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative protein damage is associated with poor grip strength among older women living in the community.
    Howard C; Ferrucci L; Sun K; Fried LP; Walston J; Varadhan R; Guralnik JM; Semba RD
    J Appl Physiol (1985); 2007 Jul; 103(1):17-20. PubMed ID: 17379753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.